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Abstract Prostate carcinomas are surrounded by a layer of
stromal fibroblastic cells that are characterized by increased
expression of CD90. These CD90
+ cancer-associated
stromal fibroblastic cells differ in gene expression from
their normal counterpart, CD49a
+CD90
lo stromal smooth
muscle cells; and were postulated to represent a less
differentiated cell type with altered inductive properties.
CD90
+ stromal cells were isolated from tumor tissue
specimens and co-cultured with the pluripotent embryonal
carcinoma cell line NCCIT in order to elucidate the impact
of tumor-associated stroma on stem cells, and the ‘cancer
stem cell.’ Transcriptome analysis identified a notable
decreased induction of smooth muscle and prostate stromal
genes such as PENK, BMP2 and ChGn compared to
previously determined NCCIT response to normal prostate
stromal cell induction. CD90
+ stromal cell secreted factors
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DOI 10.1007/s12307-010-0061-4induced an increased expression of CD90 and differential
induction of genes involved in extracellular matrix
remodeling and the RECK pathway in NCCIT. These
results suggest that, compared to normal tissue stromal
cells, signaling from cancer-associated stromal cells has a
markedly different effect on stem cells as represented by
NCCIT. Given that stromal cells are important in
directing organ-specific differentiation, stromal cells in
tumors appear to be defective in this function, which
may contribute to abnormal differentiation found in
diseases such as cancer.
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protein with Kazal motifs (RECK)
Introduction
The prostate is a glandular organ composed of secretory
luminal cell-lined acini and an underlying layer of basal
cells supported within a fibromuscular stroma. In urologic
organ development, the stroma provides the inductive
signaling to stem/progenitor cells to produce the resultant
tissue [1]. Increasingly, it is thought that the stromal
environment might play a significant role in disease
development and progression as well. An altered stroma
has been identified in association with both prostate cancer
[2–4] as well as premalignant prostate diseases including
prostatic intraepithelial neoplasia (PIN) and benign prostatic
hyperplasia (BPH) [3, 5]. In prostate cancer, the stroma is
also affected in that gene expression in cancer-associated
fibroblastic (CAF) stromal cells differs significantly from
that of normal tissue stromal cells [6–10]. Prostate CAFs
are capable of inducing proliferation and malignant trans-
formation [1] and have been postulated to drive tumor
progression [11]. These studies strongly suggest that the
prostate stroma plays a significant role in facilitating
disease progression.
CAFs immediately surrounding prostate cancer can be
identified by strong CD90 immunostaining [12] and CD90
hi
cancer-associated fibroblasts (CAFs) were postulated to have
greater tumor-promoting effects than CD90
lo CAFs [10].
Comparative transcriptome analysis of isolated CD90
+ CAFs
and CD49a
+ normal tissue stromal cells revealed a
decrease in the expression of genes involved in smooth
muscle cell differentiation and those specific or restricted
t ot h ep r o s t a t e[ 5, 7]. Genes that encode secreted proteins
or hormones are likely candidates responsible for organ-
specific stromal induction, and dysregulation of these
genes might contribute to disease progression through
stromal-stem cell signaling.
To examine the molecular mechanisms involved in
prostate stromal-stem cell interaction, we previously devel-
oped an in vitro co-culture system with stromal cells
isolated from normal prostate (referred to as NP) and a
cancer stem cell type, the embryonal carcinoma (EC) cell
line, NCCIT [13]. NCCIT is a pluripotent cell line that can
be readily maintained in cell culture in an undifferentiated
state [14]. When co-cultured without direct cell contact,
NCCIT cells were induced by NP stromal cells to
differentiate into a cell population that expressed predom-
inantly prostate stromal cell genes (e.g., PENK). Induced
NCCIT cells also lost expression of stem cell genes and
underwent a change in morphology with reduced prolifer-
ation [13]. Bladder stromal cells isolated from human
specimens induced a bladder stromal-like expression (e.g.,
absent PENK) [13], thus demonstrating plasticity—a
property of stem cells—in NCCIT response. This cell-
to-cell signaling was presumab l ym e d i a t e db yd i f f u s i b l e
factors. Interestingly, NP prostate stromal cells were also
significantly altered by co-culture with NCCIT, whereas
NCCIT had no significant effect on the gene expression
of CP stromal cells [15]. In this study, NCCIT induced an
increase in expression for CD90, MIRN21, HGF, SFRP1,
BGN, and decreased expression of IGFBP5, HSD11B1a in
NP stromal cells. These findings suggest that alterations in
prostate stroma could be induced by stem or cancer stem
cell influence. In this study, we examined the inductive
functioning of cultured CD90
+ CAFs (referred to here as
CP) stromal cells for comparison to that of NP stromal
cells.
Materials and Methods
Cell Lines and Tissue Specimens
NCCIT and prostate cancer cell line PC3 cells were obtained
from American Type Culture Collection (Manassas, VA) and
cultured in RPMI-1640 (Cambrex BioScience, Walkersville,
MD) media supplemented with 10% heat-inactivated fetal
bovine serum (FBS). In this culture condition, NCCIT cells
maintain expression of stem cell genes and microRNA, and
are alkalinephosphatase positive[13, 15]. The tissue samples
used in this study consisted of cancer-enriched CP tissue
specimens, characterized as CD90
hiTIMP1
lo by Western blot
analysis of tissue digestion media [7], obtained from 2
radical prostatectomy surgery patients. Note ‘pure’ CP
specimens had increased CD90 expression and minimal
reactivity to TIMP1, which is secreted by luminal cells and
not by cancer cells [16], whereas NP specimens were
CD90
loTIMP1
hi. All tissue samples were obtained under
approval by the University of Washington IRB and were
collected following a standard protocol. Upon receipt of a
52 L.E. Pascal et al.resected specimen, 3-mm thick transverse sections were
made of the gland after inking the exterior surface. Frozen
sections of tissue blocks were histologically prepared to
locate the tumor foci for dissection. Pathology characteristics
of the 2 tumors were 08-021CP: Gleason 5+4, T3a, tumor
volume 4.5 cc; 08-028CP: Gleason 3+4, T2c, tumor volume
2.5 cc. NP specimens were obtained and analyzed as
described previously [13]. Briefly, between 1 and 10 g of
tissue from the anterior aspect of the prostate (transition
zone) were excised; corresponding frozen sections of the
tissue blocks were histologically assessed to confirm speci-
mens were free of cancer.
Tissue samples were minced and digested by overnight
incubation at room temperature in 0.2% collagenase type I
(Invitrogen, Carlsbad, CA) in RPMI-1640 media supple-
mented with 5% FBS and 10
−8 M dihydrotestosterone on a
magnetic stirrer. The resultant cell suspension was filtered
with a 70-μm Falcon cell strainer to remove any non-
digested tissue, diluted with an equal volume of Hanks
balanced salt solution (HBSS), and aspirated with an 18-
gauge needle. The single cell preparation was partitioned
into stromal and epithelial fractions on a discontinuous
Percoll density gradient (Amersham Pharmacia, Piscataway,
NJ) as described [17, 18]. Cells banding at a density of ρ=
1.035 were collected as the stromal fraction for magnetic cell
sorting (MACS). The cell-free tissue digestion media
supernatant was analyzed by Western blotting to verify that
the specimens were of cancer.
CP stromal cells were sorted using anti-CD90. Briefly,
the gradient-purified stromal cell fraction was resuspended
in 100 μl 0.1% bovine serum albumin (BSA)-HBSS, and
CD90-Phycoerythrin (PE) mouse monoclonal antibody
(clone 5E10, BD-PharMingen, San Diego, CA) at 1:20
was added for 15 min at room temperature in the dark. The
reaction was stopped by 1 ml 0.1% BSA-HBSS and
centrifugation. The labeled cells were resuspended in
BSA-HBSS, and 15 μl paramagnetic microbead conjugated
anti-PE (Miltenyi Biotec, Auburn, CA) was added for
15 min. After incubation, the positive and negative cells
were separated by AutoMACS (Miltenyi Biotec) using the
double positive sort program. Aliquots of positive and
negative cell fractions were analyzed by fluorescence-
activated cell sorting (FACS, Becton Dickinson, Mountain
View, CA) to gauge the sort efficiency; only >85% CD90
+
fractions were used for experiments.
Cell Culture
The sorted CD90
+ stromal cells were adapted to culture
for 3–5 passages in RPMI-1640 media supplemented with
10% FBS, and their identity verified by RT-PCR analysis
of gene expression as described [5]. For co-culture
experiments, 0.4 μm polycarbonate membrane trans-well
inserts (Corning, Corning, NY) to preclude cell contact
were employed. NCCIT cells were seeded at 10
4/ml in
RPMI-1640, 10% FBS on 6-well plates, and CP stromal
cells were seeded at 10
4/ml on the insert. Controls were
NCCITand CP stromal cells alone. Cultures were maintained
for 3 d. The 3 d-time point was chosen based on our previous
time course study of NP stromal cell-induced differentiation
of NCCIT [13]. In that experiment, gene expression changes
in NCCIT were detected as early as 6 h in co-culture, and by
the third day, nearly the entire stromal gene repertoire was
induced as shown by a principal components analysis of
time-point transcriptomes. Cells were trypsinized and lysed
in RLT Buffer (Qiagen, Valencia, CA).
Transcriptome Analysis
RNA was isolated from cultures of CP stromal, NCCIT,
and NCCIT + CP stromal cells at 3 d. Transcriptomes of
untreated NCCIT, NP stromal cells and NCCIT at 3 d of
co-culture with NP stromal cells were determined
previously [13], as were sorted CD90
+ CP stromal cells,
i.e., not cultured [7]. These datasets were made available
online (http://scgap.systemsbiology.net/data/). Quality and
concentration of RNA were determined using an Agilent
2100 Bioanalyzer and RNA Nano Labchip (Agilent
Technologies, Santa Clara, CA). Between 2 and 7
replicates of each experimental condition or control were
assayed with the Human Genome U133 Plus 2.0 GeneChips
(Affymetrix, Santa Clara, CA). The U133 Plus 2.0 array
contains probesets representing 54,675 genes, splice variants,
and ESTs. The GeneChips were prepared, hybridized, and
scanned according to the protocols provided by Affymetrix
(P/N 702232 Rev. 2). Briefly, 200 ng of RNA was reverse
transcribed with poly (dT) primer containing a T7
promoter, and the cDNA was made double-stranded. In
vitro transcription was performed to produce unlabeled
cRNA. Next, first-strand cDNA was produced with
random primers, and the cDNA was made double-stranded
with poly (dT) primer/T7 promoter. A final in vitro
transcription was done with biotinylated ribonucleotides.
The biotin-labeled cRNA was hybridized to the GeneChips.
The chips were washed and stained with streptavidin-PE
using an Affymetrix FS-450 fluidics station. Data was
collected with an Affymetrix GeneChip Scanner 3000.
Bioinformatic Analysis
A probabilistic comparative analysis between transcrip-
tomes of treated NCCIT was used to highlight differentially
expressed genes with respect to that of untreated NCCIT
[7]. Gene expression level was defined as the normalized
and summarized intensities of each GeneChip probeset, and
was presented as its logarithmic value: X=log2(Normalized
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+ Prostate Stroma 53intensity). This step was carried out using the standard
robust multi-array average (RMA) method [19], imple-
mented in the in-house analysis pipeline SBEAMS [20].
Data were presented on a grayscale indicating RMA-
normalized Affymetrix signal intensity [21]. Signals of 10
or less were represented as white and signals greater than or
equal to 10,000 as black. Higher Affymetrix signal (more
black) indicated higher levels of gene expression.
The strength of differential expression between any pair
of experiments was estimated by Mi ¼ log2 ratio ðÞ ¼
X3d   X0h, where 0 h represented the untreated NCCIT
and 3d represented treated NCCIT at 3 d. Reliability of the
differential expression was estimated by calculating the
probability P=P(X3d>X0h)o rP=P(X3d<X0h) according to a
statistical model that assumed a normal distribution Xj∼N
(mj,sj), where mj and sj were the mean and maximum
difference, respectively, among the replicates of group j.
Consistently, P=P(X3d>X0h)o rP=P(X3d<X0h)w a s
reported if m3d>m0h or m3d<m0h. Functional and ontology
enrichment analysis was performed using the DAVID web-
based tool [22]. Freely available prediction software for
determination of signal peptides and likely cell membrane-
spanning sequences was also used. Signal peptides were
predicted using SignalP 3.0 [23], and transmembrane
(TM) regions were predicted using TMHMM 2.0 [24]f o r
protein topology and the number of TM helices. Informa-
tion from both SignalP and TMHMM were combined to
identify proteins that contained predicted cleavable signal
peptides and no predicted TM segments as reported
previously [25].
Results
Gene expression changes induced in NCCIT by secreted
factors from CP stromal cells were determined by Affyme-
trix DNA microarray analysis. Following 3-days co-culture
with CP stromal cells, the induced expression in NCCIT
cells (CP-NCCIT) of smooth muscle genes ACTA2,
CALD1, CNN1, prostate stromal genes PENK, CNTN1,
ChGn, BMP2 [5, 7], androgen receptor (AR) and a stromal
gene GFRA1 was significantly less than that previously
shown by NP stromal cells (NP-NCCIT) [13]. The CP-
NCCIT transcriptome dataset contained minimal signal
levels for CALD1, and CNN1 compared to that of NP-
NCCIT (Fig. 1a and b). Other queried prostate genes such
as tenascin C (TNC) [5] were also lacking. The similar
induction of stromal gene stanniocalcin (STC1) and
increased expression of CD90/THY1 in CP-NCCIT showed
that gene expression changes did occur in NCCIT co-
cultured with CP stromal cells. Induction of CD90 was
notably higher in CP-NCCIT than in NP-NCCIT (NCCIT
cells are also positive for CD90, a stem cell marker). This
reflected the increased CD90 expression in CP stromal
cells.
A comparison of stem cell gene expression in treated
NCCIT showed higher signal levels of NANOG, POU5F1,
TDGF1, and SOX2 in CP-NCCIT than in NP-NCCIT
(Fig. 1c and d). Induction of NCCIT by NP stromal cells
was found to lead to almost complete down-regulation of
these stem cell genes [13], whereas CP stromal cells had
apparently little effect. Of note was the detection of
ABCG2 (a prostate progenitor cell marker) expression in
NP-NCCIT but not CP-NCCIT (Fig. 1d). NCCIT is
negative for ABCG2 expression.
To identify genes encoding secreted proteins that
might function in cell-cell signaling, the most differen-
tially expressed genes in NP-NCCIT vs. CP-NCCIT (or
NP stromal vs. CP stromal) were analyzed using the
DAVID annotation tool. CP stromal induction led to up-
regulation of several such genes including LEFTY2 and
TAC1, while NP stromal induction led to up-regulation
of ADAMTS1, IGFBP5, WNT5A and others (Table S1).
Overall, there were many more such genes induced in NP-
NCCIT than CP-NCCIT. This showed a smaller pool of
candidate signaling molecules produced by CP stromal
cells.
Differentially expressed genes were also analyzed for
significant enrichment with respect to functional categories
using DAVID. The top KEGG pathways identified were
cytokine-cytokine receptor interaction, chemokine signaling
pathway, extracellular matrix (ECM)-receptor interaction,
cell adhesion and focal adhesion. Enrichment of these
functional categories was prominent in the CP-NCCIT vs.
NP-NCCIT datasets. Of particular interest were the genes
that contribute to the functioning and maintenance of ECM.
Matrix metalloproteinases (MMPs) are involved in the
degradation of ECM proteins and have been associated with
tumor cell invasion. The membrane-anchored reversion-
inducing cysteine-rich protein with Kazal motifs (RECK) is
a potent inhibitor of MMP activity. RECK down-regulation
has been identified in many cancers, and it has been
reported that high RECK expression levels were associated
with favorable prognosis in prostate cancer [26, 27]. In
comparing the CP-NCCIT and NP-NCCIT expression
profiles, several genes associated with RECK were differ-
entially expressed (Fig. 2a). For example, induction of
MMP9, a potential prostate cancer urine biomarker [28],
was greater in CP-NCCIT than in NP-NCCIT (Fig. 2b).
MMP9 expression was also higher in sorted CP vs. NP
stromal cell transcriptomes. In contrast, RECK was more
up-regulated in NP-NCCIT than CP-NCCIT, as was tissue
inhibitor of metalloproteinase TIMP1, an antagonist of
MMPs. With regard to the possible genesis of CP stromal
54 L.E. Pascal et al.cells, we also examined the effect of NCCIT factors on NP
stromal cells [15]. NCCIT extracts, when injected into
differentiated cells, can activate expression of stem cell
genes [29]. Instead of extract injection, NCCIT factors were
examined in the co-culture format with NP stromal cells.
We found that at day 3, the co-cultured NP stromal cells
showed a gene expression profile for both mRNA and
microRNA resembling that of CP stromal cells. Thus, CP
stromal cells appear to represent a more primitive cell type
in the stromal lineage. This is certainly in line with their
lower expression of smooth muscle cell genes, and CP
stromal cells are characterized by a loss of smooth muscle
differentiation [3]. The basal epithelium also contains the
progenitor cell population, which could affect stromal cell
differentiation. To isolate enough CD90
+ NP stromal cells
for study presents a technical challenge because of their low
number, which necessitates the need to obtain large tissue
specimens for sorting.
Figure 3 illustrates the RECK pathway network in which
MMPs synthesized by CP stromal cells could lead to ECM
degradation, which would in turn promote tumor cell
escape. The MMP effect is amplified by the decrease in
TIMP expression in cancer cells. Increase in MMPs is due
to down-regulation of RECK.
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Fig. 1 Expression profiles of stromal and stem cell genes in treated
NCCIT. a Increased expression of prostate stromal cell-specific genes
relative to untreated NCCITwas detected in co-cultures of NP stromal +
NCCIT cells (labeled NP-NCCIT). Expression of these stromal genes
was less pronounced in co-culture of CP stromal + NCCIT cells (CP-
NCCIT). For example, PENK was not induced. Note the increase in
tumor-associated stromal marker CD90/THY1. b The CP-NCCIT
transcriptome dataset (first column) contains minimal signal for smooth
muscle differentiation genes (CALD1, CNN1) present in the NP-
NCCIT transcriptome (third column) compared to untreated NCCIT
transcriptome (second column) in virtual Northern blot format (darker
shades of boxes indicate higher mRNA levels with background ≤50
RMA units). c Higher expression of several stem cell genes was
detected in CP-NCCIT relative to NP-NCCIT as well as in cultured CP
stromal cells relative to NP stromal cells. d Virtual Northern blot format
shows that for stem cell genes NANOG, SOX2, CD9 and THY1,
expression was increased in CP-NCCIT compared to untreated NCCIT,
whereas expression was decreased in NP-NCCIT
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NCCIT response to CD90
+ CAFs tumor-associated was
significantly altered from the gene expression changes
induced by normal stromal cell factors. Previously, NP
stromal cells induced a loss of embryonic stem cell markers
and an up-regulation of genes characteristic of stromal
mesenchyme, some epithelial genes and cancer stem cell
genes. NCCIT response to CP stromal cells was character-
ized by an absence or decreased induction of genes
involved in smooth muscle cell differentiation and those
expressed by the prostate but not the bladder, i.e., organ
restricted. At the same time, the decrease in stem cell gene
expression was not as pronounced. This altered differenti-
ation response could be due to differences in signaling
factors secreted from tumor-associated stromal cells. These
differences could be the result of either a reduction or loss
of certain proteins such as the hormone PENK. Stromal
cells are important in tissue repair and renewal as suggested
by their demonstrated role in prostate and bladder forma-
tion. Organ specificity in this process could be due to the
differentially expressed genes between the stromal cell
types. Indeed, we previously showed that bladder stromal
cells induced a different response from NCCIT than
prostate stromal cells. Thus, if tumor-associated stromal
cells were unable to provide the appropriate signaling, then
normal histodevelopment would not occur, instead cancer
development takes place.
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Fig. 2 Expression of RECK genes in prostate cancer. a Relative
expression of RECK, TIMP1 and MMP9 induced by CP vs. NP
stromal cells in NCCIT. The average array signal values for 2
experiments (NP1, NP2, CP1, CP2) are tabulated, which were used to
generate the histogram. b Relative expression profile of genes
involved in ECM remodeling in sorted stromal and epithelial cells
from tumor vs. normal tissue. Positive values indicate up-regulation in
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56 L.E. Pascal et al.Although only two cases of CP stromal cells were tested,
they did provide a demonstration that stem cell induction
was markedly different from that by NP stromal cells.
These differences, including reduced induction of smooth
muscle cell genes and increased induction of genes
involved in ECM remodeling, are consistent with alterations
to the prostate tumor microenvironment. When we can model
epithelial cytodifferentiation, i.e., PSA secretion, with cell
contact and ECM, then a study using multiple samples of CP
stromal cells can be carried out. For example, one could
contrastthe effectofCP stromal cells isolated fromGleason 3
+3vs.Gleason4+4tumors.
The differentially induced expression pattern of genes
involved in the ECM RECK pathway in CP-NCCIT vs.
NP-NCCIT appears to mimic that in primary tumors as
inferred from the transcriptomes of sorted stromal and
epithelial cell types. NP stromal induction produced up-
regulation of TIMP1 and RECK whereas CP stromal
induction produced up-regulation of MMP9 and compara-
tively less of TIMP1 and RECK. In the sorted cells,
expression of MMP9 (and HRAS, which inhibits RECK) is
higher in CP stromal than NP stromal, whereas that of
RECK is higher in NP stromal. TIMP1 protein in cancer is
absent [16]. Thus, our in vitro model of CP stromal
induction of NCCIT recapitulated to some degree a major
pathway important in cancer development. In response to
NP stromal influence, NCCIT cells were induced to express
a transcriptome with a predominant but incomplete stromal
mesenchyme profile. However, the response to CP stromal
cell influence with regard to induction of stromal mesen-
chyme genes and loss of stem cell genes was significantly
less. This difference could simply reflect a reduction in
secreted factors from CP stromal cells compared to NP
stromal cells and therefore a lesser degree of influence on
NCCITcells, or it could represent a shift in the heterogeneity
of the treated NCCITcell population.
With regard to the possible genesis of CP stromal cells,
we also examined the effect of NCCIT factors on NP
stromal cells [15]. NCCIT extracts, when injected into
differentiated cells, can activate expression of stem cell
genes [29]. Instead of extract injection, NCCIT factors were
examined in the co-culture format with NP stromal cells.
We found that at day 3, the co-cultured NP stromal cells
showed a gene expression profile for both mRNA and
microRNA resembling that of CP stromal cells. Thus, CP
stromal cells appear to represent a more primitive cell type
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Fig. 3 Schematic of RECK pathway in stromal–epithelial interaction
in prostate cancer. Decreased RECK expression leads to activation of
MMPs and degradation of ECM proteins allowing dissemination of
tumor cells. Virtual Northern blot format shows array signals for
MMP9, HRAS and RECK in NP stromal vs. CP stromal cells (1 and 2
from two different specimens) and for TIMPs in NP epithelial vs. CP
cancer cells
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+ Prostate Stroma 57in the stromal lineage. This is certainly in line with their
lower expression of smooth muscle cell genes, and CP
stromal cells are characterized by a loss of smooth muscle
differentiation [3]. The basal epithelium also contains the
progenitor cell population, which could affect stromal cell
differentiation. To isolate enough CD90
+ NP stromal cells
for study presents a technical challenge because of their low
number, which necessitates the need to obtain large tissue
specimens for sorting.
In summary, these experimental results showed that in
induction of stem cells CP stromal cells were very different
from NP stromal cells. The abnormal gene expression of
CP stromal cells may well be the cause. Whether this would
lead to cancer cell differentiation is still unknown since
heterotypic cell contact and ECM were not provided for in
the co-culture. Also unknown is whether other cell types
beside stromal (e.g., epithelial) were induced in this system.
For example, some ABCG2 expression was detected in NP-
NCCIT, and this may suggest a small subpopulation with
this marker. ABCG2 expression was identified in a putative
prostate progenitor cell population localized to the basal
epithelium [30]. It is therefore possible that more than one
cell lineage, stromal and epithelial, could result from
stromal induction of stem cells.
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